393 completed, 329 unknown, 310 recruiting, 142 not yet recruiting. 678 Phase 2, 264 Phase 3, 183 Not applicable, 180 Phase 1, 46 Phase 4.
Follow Drug Therapy: new trials by email Literature Review of Drug Therapy trials Research Report on Drug Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome Shuganhuazhuo Formula, Targeted therapy, Immunotherapy - HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine | Phase 2 | Not yet recruiting | Xiang-Qian | 120 | 2027-09-01 | 2026-08-27 |
| Cannabis Gummy for the Improvement of Sleep and Quality of Life in Patients With Cancer, Pillow Trial Actigraphy, Best Practice, Biospecimen Collection - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Phase 1 / Phase 2 | Not yet recruiting | Theodore Brasky PhD | 50 | 2027-01-15 | 2026-10-14 |
| BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Not yet recruiting | City of Hope Medical Center | 19 | 2026-12-14 | 2026-05-13 |
| Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma 3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection - Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | National Cancer Institute (NCI) | 374 | 2026-12-04 | 2026-07-08 |
| Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy, Cemiplimab, Chemotherapy - Glioblastoma, Glioblastoma, IDH-wildtype | Phase 2 | Not yet recruiting | Washington University School of Medicine | 99 | 2026-11-30 | 2026-10-20 |
| A Phase I Study of HS-20093 Injection in Combination Therapy in Non-Small Cell Lung Cancer HS-20093, Ivonescimab, Chemotherapy - Non-Small Cell Lung Cancer | Phase 1 | Not yet recruiting | Hansoh BioMedical R&D Company | 102 | 2026-11-10 | 2026-10-27 |
| SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung Cancer SSGJ-706, SPGL008, Chemotherapy - Non Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Shenyang Sunshine Pharmaceutical Co., LTD. | 220 | 2026-11-01 | 2026-10-15 |
| Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma. FMT combined with chemotherapy plus immunotherapy, Chemotherapy+Immunotherapy - Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 2 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 40 | 2026-11-01 | 2026-10-02 |
| Off-Label Treatment With Immune Checkpoint Inhibitor Blockade One or more off-label ICIs alone or with other on-label ICI(s), Off-label ICI(s) with targeted therapy, off-label ICI(s) with other agents that are not targeted (including, but not limited to, chemotherapy, hormonal therapy, immunotherapy other than ICIs) with or without targeted agents - Malignancy | Phase 2 | Not yet recruiting | Medical College of Wisconsin | 231 | 2026-11-01 | 2026-08-10 |
| Optimizing Response to Immunotherapy With Online Adaptive Pulsed Radiotherapy in Incurable Head and Neck Cancers Pulsed Adaptive Radiotherapy Combined with Pembrolizumab with or without chemotherapy - Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | Not yet recruiting | University Health Network, Toronto | 48 | 2026-11-01 | 2026-10-22 |
| Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma Ivonescimab Combined With Chemotherapy - Malignant Pleural Mesothelioma, Advanced | Phase 1 / Phase 2 | Recruiting | Ruijin Hospital | 78 | 2026-11-01 | 2026-10-26 |
| IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer FH-STEAP1 IL-18 CAR T cells, Antiandrogen Therapy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 1 | Not yet recruiting | Fred Hutchinson Cancer Center | 20 | 2026-10-31 | 2026-09-04 |
| Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases Immunotherapy, Chemotherapy (Etoposide, Nab-paclitaxel, Irinotecan, or Lurbinectedin), low-dose radiation - Lung Cancer (SCLC) | Phase 2 | Not yet recruiting | Sichuan University | 30 | 2026-10-31 | 2026-05-05 |
| A Study of Perioperative Adebrelimab Plus Chemotherapy Versus Adjuvant Therapy in Patients With Resectable NSCLC Adebrelimab (SHR-1316) + chemotherapy, Adebrelimab - Non-small Cell Lung Cancer (NSCLC) | Phase 3 | Not yet recruiting | West China Hospital | 1088 | 2026-10-31 | 2026-10-26 |
| Primary Radiotherapy In MEtastatic Lung Cancer Radiotherapy followed by chemotherapy, Standard of Care (SOC) - Carcinoma, Non-Small-Cell Lung (NSCLC) | Phase 3 | Recruiting | Trans Tasman Radiation Oncology Group | 420 | 2026-10-30 | 2026-10-23 |
| Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden Tislelizumab, Tislelizumab Combined With Chemotherapy, Pembrolizumab - Non-small Cell Lung Cancer Metastatic | Phase 3 | Not yet recruiting | AIO-Studien-gGmbH | 230 | 2026-10-30 | 2026-10-26 |
| Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSS short-course radiotherapy, Serplulimab, CapOx(Capecitabine+ Oxaliplatin) - Locally Advanced Colon Cancer, pMMR | Phase 3 | Not yet recruiting | Fudan University | 480 | 2026-10-15 | 2026-10-16 |
| A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment Chemotherapy, Immunotherapy, Intensity-Modulated Radiation Therapy - Lung Non-Small Cell Carcinoma | Phase 2 | Recruiting | Alliance for Clinical Trials in Oncology | 164 | 2026-10-14 | 2026-10-19 |
| Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms Topotecan - usual, Topotecan - study - SCLC | Phase 2 / Phase 3 | Active not recruiting | Han Xu, M.D., Ph.D., FAPCR, Medical Director, IRB Chair | 600 | 2026-10-05 | 2026-10-08 |
| THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia Biospecimen Collection, Placebo Administration, Single Agent Therapy - Insomnia, Malignant Solid Neoplasm | Phase 2 | Not yet recruiting | Mayo Clinic | 69 | 2026-10-01 | 2026-09-02 |
Showing 20 of 1394. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (167) · Breast Neoplasms (112) · Colorectal Neoplasms (77) · Neoplasms (65) · Lung Neoplasms (61) · Pancreatic Neoplasms (57) · Neoplasm Metastasis (52) · Stomach Neoplasms (52) · Ovarian Neoplasms (45) · Rectal Neoplasms (44) · Esophageal Neoplasms (40) · Esophageal Squamous Cell Carcinoma (40) · Squamous Cell Carcinoma of Head and Neck (36) · Head and Neck Neoplasms (35) · Leukemia, Myeloid, Acute (32)
Fudan University (43) · Sun Yat-sen University (35) · Tianjin Medical University Cancer Institute and Hospital (21) · Hoffmann-La Roche (18) · Peking Union Medical College Hospital (18) · M.D. Anderson Cancer Center (16) · National Cancer Institute (NCI) (14) · Ruijin Hospital (13) · Zhejiang Cancer Hospital (13) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (12) · Sichuan University (12) · Pfizer (11) · Second Affiliated Hospital, Zhejiang University, School of Medicine (10) · Shanghai Chest Hospital (10) · Mayo Clinic (9)
China (529) · United States (355) · France (109) · Italy (94) · Germany (75) · Spain (75) · Canada (55) · United Kingdom (51) · South Korea (49) · Belgium (47) · Netherlands (46) · Australia (42) · Taiwan (34) · Switzerland (33) · Poland (32)
You Lu, MD (4) · Birendra K Sah, PH D (3) · Chen Li, PH D (3) · Hongmeng Yu, MD,PHD (3) · Paul Schwarzenberger, MD (3) · Tao Ouyang, MD (3) · Yongchang Zhang, MD (3) · Zhenggang Zhu, PH D (3)
PMID 40812353, PMID 26808342, PMID 28596308, PMID 30062662, PMID 35143424, PMID 37185961, PMID 37280366, PMID 38572751, PMID 39368878, PMID 40288679, PMID 40467307, PMID 10332020, PMID 10473315, PMID 10581077, PMID 10655437, PMID 10660394, PMID 10742367, PMID 10813118, PMID 10870204, PMID 10996924, PMID 11171826, PMID 11188984, PMID 11208820, PMID 11254763, PMID 11299481, PMID 11556297, PMID 11560968, PMID 11675328, PMID 11870157, PMID 11937316, PMID 11971127, PMID 12177103, PMID 12434281, PMID 12436398, PMID 12525193, PMID 1418457, PMID 14506149, PMID 14645425, PMID 14645636, PMID 15128893, PMID 15131031, PMID 15151953, PMID 15383798, PMID 15496622, PMID 15534360, PMID 15812833, PMID 15816939, PMID 15928658, PMID 15936546, PMID 15939524
2017 (11), 2023 (11), 2016 (9), 2025 (7), U10CA180820 (5), 2018 (4), 2009 (3), 2014 (3), 2015 (3), P30CA015704 (3), P30CA016672 (3), P30CA033572 (3), U10CA031946 (3), 2005 (2), P30CA006973 (2)